Disclosed is a blue light absorbing compound, its preparation method and use. The compound has high stability and is suitable for high temperature processing conditions as well as outdoor application. A method of covalently bonding a blue light absorbing compound with an ultraviolet light absorbing compound for increasing its stability is also provided. The compound is capable of absorbing or blocking ultraviolet light (UVA, UVB) and blue light to protect eyes. But long-wavelength blue light can be absorbed diminishingly, so that the transmitted light has a particularly good visual experience.

##STR00001##

Disclosed herein are small molecule Vascular Adhesion Protein-1 (VAP-1) modulator compositions, pharmaceutical compositions, the use and preparation thereof.

Disclosed herein are small molecule Vascular Adhesion Protein-1 (VAP-1) modulator compositions, pharmaceutical compositions, the use and preparation thereof.

The present invention can provide a method having superior crop selectivity for weed control in a cultivation area of field corn. The method includes a step of applying trifludimoxazin in a cultivation area of field corn.

The present invention can provide a method having superior crop selectivity for weed control in a cultivation area of field corn. The method includes a step of applying trifludimoxazin in a cultivation area of field corn.

The present invention provides a compound, and method of inhibiting the activity of a Fatty Acid Binding Protein (FABP) comprising contacting the FABP with a compound, said compound having the structure: Formula (I)

##STR00001##

The present invention provides a compound, and method of inhibiting the activity of a Fatty Acid Binding Protein (FABP) comprising contacting the FABP with a compound, said compound having the structure: Formula (I)

##STR00001##

A fluorine-containing ether compound characterized by being represented by the following formula (1):

R.sup.1—R.sup.2—CH.sub.2—R.sup.3—CH.sub.2—R.sup.4—R.sup.5  (1)

In the formula (1), R.sup.3 is a perfluoropolyether chain. R.sup.2 and R.sup.4 are divalent linkage groups having a polar group and may be the same or different. R.sup.1 and R.sup.5 are bonded to an atom other than a carbon atom of R.sup.2 or R.sup.4. R.sup.1 and R.sup.5 are terminal groups composed of an organic group having 1 to 8 carbon atoms and may be the same or different. At least one of R.sup.1 and R.sup.5 is a chain organic group having 1 to 8 carbon atoms wherein one or more hydrogen atoms of the chain organic group is substituted with a group having an amide bond.

The present invention provides a compound, and method of inhibiting the activity of a Fatty Acid Binding Protein (FABP) comprising contacting the FABP with a compound, said compound having the structure: Formula (I). ##STR00001##

The present invention provides a compound, and method of inhibiting the activity of a Fatty Acid Binding Protein (FABP) comprising contacting the FABP with a compound, said compound having the structure: Formula (I). ##STR00001##